Stefanos Bamopoulos

6PUBLICATIONS
49CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical biotechnology diagnostics (incl. biosensors)Predictive and prognostic markersMolecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 20, 2024
Activation of gp130 signaling in T cells drives TH17-mediated multi-organ autoimmunity.

Francis Baumgartner, Stefanos A Bamopoulos, Laura Faletti

|Dec 08, 2023
Comparing malignant monocytosis across the updated WHO and ICC classifications of 2022.

Francis Baumgartner, Constance Baer, Stefanos Bamopoulos

|Sep 23, 2022
Germline SNPs previously implicated as prognostic biomarkers do not associate with outcomes in intensively treated AML.

Aarif M N Batcha, Nele Buckup, Stefanos A Bamopoulos

|Aug 02, 2022
SUMOylation inhibition overcomes proteasome inhibitor resistance in multiple myeloma.

Guus J J E Heynen, Francis Baumgartner, Michael Heider

|Feb 24, 2022
NOXA expression drives synthetic lethality to RUNX1 inhibition in pancreatic cancer.

Josefina Doffo, Stefanos A Bamopoulos, Hazal Köse

Pageof 1